Lightcalls.com
 

The statistics forward depression a...

The statistics forward depression are downright depressing. According to the National Mental Health Association, more [i]or[/i] less 12 million American women sustain from clinical depression in any given year and single in five will experience it sometime in her lifetime. While depression is an equal opportunity affliction, it take places most frequently in women ages 25 to 44 affecting twice as many women as men Many factors increase a woman's chance of experiencing depression, including genetic predisposition, hormonal shifts, the stresse of balancing work and family and a history of domestic violence or sexual abuse.

Unfortunately, alone about half of all reduceed women will seek professional help, and for those who do, the treatment repeatedly comes in the form of a pill, like as Prozac or Zoloft. generally more than 30 million persons are taking Prozac, ranking it among the top 10 most-prescribed remedys in the country. Recent findings, however, prompt that the Prozac tide may be turning.

arises of a nationwide survey manner of lifeed by Harvard scientists (American Journal of Psychiatry, February 2001) showed that depression sufferer are looking increasingly to nonconventional treatments. In fact, researchers lay the foundation of depression to be one of the conditions greatest in quantity likely to prompt a one to try alternative therapies. According to lead author Ronald Kessler PhD "Everybody is getting in succession the alternative therapy bandwagon." The scan indicated that the most popular alternative treatments were relaxation techniques, like as meditation, spiritual healing (prayer) and self-help groups



Respondent also reported turning to herbal remedies, vitamin therapy, massage, acupuncture, aromatherapy, yoga and diet changes.

proceeds of the survey indicate that more than half of those who experimented with alternative treatments did in such a manner without the guidance of a holistic practitioner, which raises an important issue. In the case of depression, a healthcare professional should always be deliberateed before taking any herbs or supplys because side effects may fall out if they are combined with prescription medications. Kessler discovered that no other than a small percentage told their doctor about using alternative therapies for depression because they feared being labeled a "kook" further had their doctor inquired, they would have attested "The fact that doctors don't ask," Kessler explains, "indicates an extraordinary lack of awareness upon their part. One out of four patients is doing something in addition to what her doctor has prescribed, still physicians seem wholly unfamiliar with this--that the world is changing."

COPYRIGHT 2001 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2001 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.